ABEO Abeona Therapeutics Inc

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.

As of 10/15/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/19/1980
Outstanding shares:  101,227,014
Average volume:  741,998
Market cap:   $90,152,779
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00289Y107
ISIN:        US00289Y1073
Valuation   (See tab for details)
PE ratio:   -2.36
PB ratio:   1.10
PS ratio:   6.93
Return on equity:   -64.55%
Net income %:   -417.49%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy